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   Adriamycin （ADM） was given．t．o 11 patients with vesical tumor by instillation into the
bladder． Three differept doses， narpely ，〈1） 20 mg of ADM dissolved in 20 ml of physiological
saline． solution， （2） 30 mg of ADM dissolved in the solution， and （3） 60 mg of ADM in 30 rnl
of the same， were administered to the patients divided into three groups for 3 consecutive
days． The medication was interrupted for 2 weeks before the second instillation． This way
of treatment was designated as one course of the ADM therapy by intravesical instillation．
When some favourable effects were observed on the examination of cystoscopy after the first
course， the therapy was repeated once皿ore． The丘nal llldgement of the effect of the drug
was made after the therapy of two courses （after four weeks）． The effect of the drug was
evaluated on the basis of the’?奄獅р奄獅№?of cystoscopy as well as cystogram． When the shrin－
kage of ’the tumor was more than 50％’in size after the therapy as compared with the initial
si2e bf’ tumor， the drug was considered to be． effective． When the shrinkage more than． 90％，
it was judged as markedly effect．ive． When no shrinkage or if any less than 50％ was ob－
served， it was’criticized to be ineffective． ln case that subjective symptoms or cystoscopic
findings were worsened without any noticeable anti－turnor effect after the therapy， the drug
was’ regarded as aggravated． According to the said criteria， the drug was found to be mar－
kedly effective in 2 cases， effective in 5’cases and ineffective in 4．cases． There was no ag－
gravated case． The blood level after the instillation into the bladder was very low． However，
the similar undesired side－effe．cts such as depilation which is encountered ．in the intrayenous
administration of the qrug were also ．noted in ope cas．e． Two pqt．ienis who received three
courses of the tteatmenf’ showed redness and edema on the membrane of the bladder． This
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注 入 方 法
ADMの膀胱粘膜刺激性および膀胱粘膜透過性が明
pa． tr． ca．： papillary transitional cell carcinoma
non－pa． tr． ca．： non－papillary transitional cell











 ADM濃度の測定は， B． subtilis ATCC 6633を
指示菌とした薄層カップ法でおこない，標準曲線は
pH 7．O phosphate buffer tlこより作成した．培地は
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Table 5． 第1群
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32 1 6．0 1 30．0
39 1 9．9 1 49．5
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（％） （ltg／ml）1 l hr 1 2 hrs i 6 hrs
3s・o 1 ii6．7 ［ 0
22．3 1 74．3 1 0
21．4 1 71．3 i O
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Table 7． 第3君羊
症例氏名識㌔露穰箭     （mg）
（μ9／ml） pH









6．2 1 265 1 223
5．4 1 143 1 350








6．0 1 120 1 450
6．6 L 75 1 480







































































   Fig．4．症例2ADM 3クール白蘭後の尿道膀胱撮影
    Fig・5．症例2 ADM 3クール膀注後のbiopsy
Table 8，



















supravent． premature beat， right bundlebranch block
sinus bradicardia， supravent． premature
beat， myocardial injury
left ventricular hypertrophy
sinus tachycardia， myocardial ischemia
normal
normal
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                  膀胱刺激症
状は，5例に認めた．
 Adriamycinの溶解濃度は，2，000 Pt9／ml（Adria－
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